10-K Filing

Ascent Solar Technologies, Inc. CIK: 1350102 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000950170-24-017977`
Period End Date	20231231
Filing Date	20240221
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	asti-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 43 Cash Flow Statement 74 Stockholders Equity 21

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.48M	USD	Point-in-time
Trade receivables, net of allowance of $0 and $26,000, respectively	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Trade receivables, net of allowance of $0 and $26,000, respectively	`AccountsReceivableNetCurrent`	$1.77K	USD	Point-in-time
Inventories	`InventoryNet`	$615.28K	USD	Point-in-time
Inventories	`InventoryNet`	$447.50K	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.28K	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$26.00K	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$344.11K	USD	Point-in-time
Patents, amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$173.39K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.44M	USD	Point-in-time
Patents, amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$154.22K	USD	Point-in-time
Property, Plant and Equipment:	`PropertyPlantAndEquipmentGross`	$21.18M	USD	Point-in-time
Property, Plant and Equipment:	`PropertyPlantAndEquipmentGross`	$22.59M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$22.04M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$20.13M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$551.66K	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.05M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$4.32M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.36M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Patents, net of accumulated amortization of $173,387 and $154,218, respectively	`FiniteLivedIntangibleAssetsNet`	$53.98K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Patents, net of accumulated amortization of $173,387 and $154,218, respectively	`FiniteLivedIntangibleAssetsNet`	$79.98K	USD	Point-in-time
Equity method investment	`EquityMethodInvestments`	$61.38K	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Equity method investment	`EquityMethodInvestments`	$68.87K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.23M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	259,323.00	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	259,323.00	shares	Point-in-time
Total other assets	`OtherAssets`	$3.72M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	3.58M	shares	Point-in-time
Total other assets	`OtherAssets`	$5.68M	USD	Point-in-time
Total Assets	`Assets`	$18.68M	USD	Point-in-time
Total Assets	`Assets`	$6.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$579.24K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$595.16K	USD	Point-in-time
Related party payables	`RelatedPartyPayablesCurrent`	$4.23K	USD	Point-in-time
Related party payables	`RelatedPartyPayablesCurrent`	$67.16K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$888.87K	USD	Point-in-time
Accrued payroll	`AccruedPayrollTaxesCurrent`	$490.19K	USD	Point-in-time
Accrued payroll	`AccruedPayrollTaxesCurrent`	$160.48K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$437.08K	USD	Point-in-time
Accrued professional services fees	`AccruedProfessionalFeesCurrent`	$952.57K	USD	Point-in-time
Accrued professional services fees	`AccruedProfessionalFeesCurrent`	$849.28K	USD	Point-in-time
Accrued interest	`AccruedInterestCurrent`	$628.14K	USD	Point-in-time
Accrued interest	`AccruedInterestCurrent`	$559.06K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$491.44K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$733.57K	USD	Point-in-time
Conversions payable	`ConversionsPayableCurrent`	$1.09M	USD	Point-in-time
Current portion of convertible notes, net	`ConvertibleNotesPayableCurrent`	$354.94K	USD	Point-in-time
Other payable	`NotePayableExcludingConvertibleNoteCurrent`	$250.00K	USD	Point-in-time
Other payable	`NotePayableExcludingConvertibleNoteCurrent`	$250.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.76M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.04M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.04M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.83M	USD	Point-in-time
Non-current convertible notes, net	`ConvertibleLongTermNotesPayable`	$5.27M	USD	Point-in-time
Accrued warranty liability	`StandardProductWarrantyAccrualNoncurrent`	$21.23K	USD	Point-in-time
Accrued warranty liability	`StandardProductWarrantyAccrualNoncurrent`	$21.23K	USD	Point-in-time
Total liabilities	`Liabilities`	$14.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.83M	USD	Point-in-time
Commitments and contingencies (Note 18)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 18)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($899,069 and $850,301 Liquidation Preference, respectively)	`PreferredStockValue`	$5.00	USD	Point-in-time
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($899,069 and $850,301 Liquidation Preference, respectively)	`PreferredStockValue`	$5.00	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 authorized; 3,583,846 and 259,323 shares issued and outstanding, respectively	`CommonStockValue`	$358.00	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 authorized; 3,583,846 and 259,323 shares issued and outstanding, respectively	`CommonStockValue`	$26.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$480.94M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$452.14M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-447.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-482.48M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$8.94K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.02K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.53M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-2.83M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$4.59M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$18.68M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$6.30M	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$458.26K	USD	Annual
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.22M	USD	Annual
Costs of revenue	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$2.01M	USD	Annual
Costs of revenue	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$1.89M	USD	Annual
Research, development and manufacturing operations	`ResearchAndDevelopmentExpense`	$3.22M	USD	Annual
Research, development and manufacturing operations	`ResearchAndDevelopmentExpense`	$5.98M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.74M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.36M	USD	Annual
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$5.48M	USD	Annual
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$2.24M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$75.64K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$95.24K	USD	Annual
Impairment loss	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Impairment loss	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$3.28M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$16.10M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$18.28M	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-15.64M	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-17.06M	USD	Annual
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$747.74K	USD	Annual
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$33.10K	USD	Annual
Interest expense	`InterestExpenseExcludingWarrantLiability`	$2.70M	USD	Annual
Interest expense	`InterestExpenseExcludingWarrantLiability`	$2.17M	USD	Annual
Total Other Income/(Expense)	`NonoperatingIncomeExpense`	$-1.43M	USD	Annual
Total Other Income/(Expense)	`NonoperatingIncomeExpense`	$-2.67M	USD	Annual
Income/(Loss) on Equity Method Investment	`IncomeLossFromEquityMethodInvestments`	$-232.00	USD	Annual
Income/(Loss) on Equity Method Investment	`IncomeLossFromEquityMethodInvestments`	$-27.36K	USD	Annual
Net Income/(Loss)	`NetIncomeLoss`	$-19.75M	USD	Annual
Net Income/(Loss)	`NetIncomeLoss`	$-17.07M	USD	Annual
Less: Down round deemed dividend	`DownRoundDeemedDividend`	$17.98M	USD	Annual
Net Income Available to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.07M	USD	Annual
Net Income Available to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-35.05M	USD	Annual
Net Income/(Loss) Per Share (Basic)	`EarningsPerShareBasic`	$-34.19	USD	Annual
Net Income/(Loss) Per Share (Basic)	`EarningsPerShareBasic`	$-132.00	USD	Annual
Net Income/(Loss) Per Share (Diluted)	`EarningsPerShareDiluted`	$-132.00	USD	Annual
Net Income/(Loss) Per Share (Diluted)	`EarningsPerShareDiluted`	$-34.19	USD	Annual
Weighted Average Common Shares Outstanding (Basic)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.03M	shares	Annual
Weighted Average Common Shares Outstanding (Basic)	`WeightedAverageNumberOfSharesOutstandingBasic`	149,016.00	shares	Annual
Weighted Average Common Shares Outstanding (Diluted)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.03M	shares	Annual
Weighted Average Common Shares Outstanding (Diluted)	`WeightedAverageNumberOfDilutedSharesOutstanding`	149,016.00	shares	Annual
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$24.96K	USD	Annual
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-16.02K	USD	Annual
Net Comprehensive Income/(Loss)	`ComprehensiveIncomeNetOfTax`	$-19.77M	USD	Annual
Net Comprehensive Income/(Loss)	`ComprehensiveIncomeNetOfTax`	$-17.04M	USD	Annual

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net income/(loss)	`NetIncomeLoss`	$-19.75M	USD	Annual
Net income/(loss)	`NetIncomeLoss`	$-17.07M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$75.64K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$95.24K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$2.24M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$5.48M	USD	Annual
Services paid in common stock	`IncreaseInServicesPaidInCommonStock`	$92.75K	USD	Annual
Gain on lease modification	`GainLossOnLeaseModification`	$84.68K	USD	Annual
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	$-77.21K	USD	Annual
Operating lease asset amortization	`OperatingLeaseAssetAmortization`	$694.23K	USD	Annual
Operating lease asset amortization	`OperatingLeaseAssetAmortization`	$667.53K	USD	Annual
Loss on equity method investment	`IncomeLossFromEquityMethodInvestments`	$-232.00	USD	Annual
Loss on equity method investment	`IncomeLossFromEquityMethodInvestments`	$-27.36K	USD	Annual
Patent write off	`PatentWriteOff`	$26.42K	USD	Annual
Impairment loss	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Impairment loss	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$3.28M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$2.61M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$1.81M	USD	Annual
Inventory write off and reserve expense	`InventoryWriteOffAndReserveExpense`	$114.30K	USD	Annual
Other	`Other`	$4.50K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.77K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-47.48K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$23.11K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$124.76K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-192.27K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$686.36K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableExcludingRelatedParty`	$-47.01K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableExcludingRelatedParty`	$-15.92K	USD	Annual
Related party payable	`IncreaseDecreaseInAccountsPayableRelatedParties`	$22.16K	USD	Annual
Related party payable	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-62.93K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-656.33K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-649.99K	USD	Annual
Accrued interest	`IncreaseDecreaseInAccruedInterestPayable`	$69.08K	USD	Annual
Accrued interest	`IncreaseDecreaseInAccruedInterestPayable`	$83.39K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.62M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-202.23K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.51M	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.54M	USD	Annual
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.86M	USD	Annual
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$169.36K	USD	Annual
Contributions to equity method investment	`PaymentsToAcquireEquityMethodInvestments`	$83.56K	USD	Annual
Patent activity costs	`ProceedsFromPaymentsToPatentActivity`	$-19.58K	USD	Annual
Patent activity costs	`ProceedsFromPaymentsToPatentActivity`	$-12.56K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.88M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-265.47K	USD	Annual
Proceeds from issuance of convertible debt and warrants	`ProceedsFromIssuanceOfConvertibleDebtAndWarrants`	$13.50M	USD	Annual
Proceeds from issuance of stock and warrants	`ProceedsFromIssuanceOfStockAndWarrants`	$5.00M	USD	Annual
Proceeds from issuance of stock and warrants	`ProceedsFromIssuanceOfStockAndWarrants`	$10.29M	USD	Annual
Proceeds from issuance of Series 1B Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$900.00K	USD	Annual
Payment of convertible debt and conversions payable	`PaymentOfConvertibleDebtAndConversionsPayable`	$6.24M	USD	Annual
Payment of Series 1B Preferred Stock	`PaymentsForRepurchaseOfConvertiblePreferredStock`	$900.00K	USD	Annual
Financing issuance cost	`PaymentsOfStockIssuanceCosts`	$1.09M	USD	Annual
Financing issuance cost	`PaymentsOfStockIssuanceCosts`	$2.21M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.29M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.96M	USD	Annual
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.24K	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-10.43M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.52M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.96M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.48M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.96M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.48M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$293.84K	USD	Annual
Conversions of preferred stock, convertible notes, and conversions payable to equity	`ConversionsOfPreferredStockConvertibleNotesAndConversionsPayableToEquity`	$10.51M	USD	Annual
Conversions of preferred stock, convertible notes, and conversions payable to equity	`ConversionsOfPreferredStockConvertibleNotesAndConversionsPayableToEquity`	$3.08M	USD	Annual
Series 1A preferred stock conversion	`SeriesOneAPreferredStockConversion`	$740.00	USD	Annual
Operating lease assets obtained in exchange for operating lease liabilities	`OperatingLeaseAssetsObtainedInExchangeForOperatingLeaseLiabilities`	$53.19K	USD	Annual
Purchase and return of equipment purchased on credit	`PurchaseAndReturnOfEquipmentOnPurchasedOnCredit`	$-202.56K	USD	Annual
Purchase and return of equipment purchased on credit	`PurchaseAndReturnOfEquipmentOnPurchasedOnCredit`	$159.12K	USD	Annual
Conversion of bridge loan into common stock and warrants	`ConversionOfBridgeLoanIntoCommonStockAndWarrants`	$1.00M	USD	Annual
Conversion of prefunded warrants	`ConversionOfPrefundedWarrants`	$247.00	USD	Annual
Down round deemed dividend	`DownRoundDeenedDividend`	$17.98M	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$-1.53M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-2.83M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$4.59M	USD	Point-in-time
Conversion of shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$6.99M	USD	Annual
Warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.99M	USD	Annual
Beneficial conversion feature	`BeneficialConversionFeature`	$4.49M	USD	Annual
Proceeds from issuance of Series 1B Preferred Stock	`StockIssuedDuringPeriodValueNewIssues`	$900.00K	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$92.75K	USD	Annual
Issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$20.00K	USD	Annual
Down round deemed dividend	`AdjustmentsToDownRoundDeemedDividend`	$17.98M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.48M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.24M	USD	Annual
Repayment of Series 1B Preferred Stock	`AdjustmentsToAdditionalPaidInCapitalStockRepaymentOfPreferredStock`	$900.00K	USD	Annual
Conversion of prefunded warrants (in shares)	`PreFundedWarrantsWereExercisedIntoCommonStock`	2.47M	shares	Annual
Net Loss	`NetIncomeLoss`	$-19.75M	USD	Annual
Net Loss	`NetIncomeLoss`	$-17.07M	USD	Annual
Foreign Currency Translation Gain/(Loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$24.96K	USD	Annual
Foreign Currency Translation Gain/(Loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-16.02K	USD	Annual
Ending balance	`StockholdersEquity`	$-1.53M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-2.83M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$4.59M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.